Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
International Journal of Oncology|October 8, 2005
Isolation and characterization of an N-linked oligosaccharide that is increased in glioblastoma tissue and cell linesNaoto Tsuchiya, Ryuya Yamanaka, Naoki Yajima, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trialRyuya Yamanaka, Junpei Homma, Naoki Yajima, et al.International Journal of Oncology|September 10, 2003
Selection of surrogate marker genes in primary central nervous system lymphomas for radio-chemotherapy by DNA array analysis of gene expression profilesRyuya Yamanaka, Shigeru Akutagawa, Fumiko Taguchi, et al.Ebiomedicine|July 28, 2018
A Nucleolar Stress-Specific p53-miR-101 Molecular Circuit Functions as an Intrinsic Tumor-Suppressor NetworkYuko Fujiwara, Motonobu Saito, Ana I Robles, et al.Leukemia & Lymphoma|June 20, 2007
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimenRyuya Yamanaka, Yoshikatsu Shinbo, Masakazu Sano, et al.Japanese Journal of Clinical Oncology|April 17, 2008
Results of treatment of 112 cases of primary CNS lymphomaRyuya Yamanaka, Ken Morii, Yoshikatsu Shinbo, et al.Journal of Drug Targeting|July 13, 2021
Ultrasound image-guided gene delivery using three-dimensional diagnostic ultrasound and lipid-based microbubblesDaiki Omata, Lisa Munakata, Saori Kageyama, et al.Scientific Reports|August 19, 2014
NEK9-dependent proliferation of cancer cells lacking functional p53Daisuke Kurioka, Fumitaka Takeshita, Koji Tsuta, et al.Plos One|December 23, 2014
Carbon-ion beam irradiation kills X-ray-resistant p53-null cancer cells by inducing mitotic catastropheNapapat Amornwichet, Takahiro Oike, Atsushi Shibata, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant gliomaNaoki Yajima, Ryuya Yamanaka, Takashi Mine, et al.Pageof 7